Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Is organ preservation in rectal cancer ready for prime time?

Each year, over 8500 patients in the UK are diagnosed with rectal cancer. Preoperative chemoradiotherapy followed by surgery reduces the risk of local recurrence by downstaging the tumour and results in cure for many patients.1,2 In 2004, Angelita Habr-Gama and colleagues3 reported their results based on 10 years of experience of avoiding surgery after chemoradiotherapy in patients with clinical complete response (cCR). Instead of surgery, they successfully performed clinical surveillance by endoscopy and digital rectal examination.